Deciding the Right Treatment Plan With AvaGen™, The Genetic Eye Test

Show Description +

Elizabeth Yeu, MD, sits down with Mile Brujic, OD, FAAO, and William B. Trattler, MD, to discuss multiple cases in which corneal maps were unable to provide a clear understanding of a proper treatment path. In each of these cases, AvaGen™(Avellino) unveiled crucial information regarding risk for keratoconus, giving Dr. Yeu a better understanding of the appropriate treatment plan.

Posted: 10/01/2021

Deciding the Right Treatment Plan With AvaGen™, The Genetic Eye Test

Elizabeth Yeu, MD, sits down with Mile Brujic, OD, FAAO, and William B. Trattler, MD, to discuss multiple cases in which corneal maps were unable to provide a clear understanding of a proper treatment path. In each of these cases, AvaGen™(Avellino) unveiled crucial information regarding risk for keratoconus, giving Dr. Yeu a better understanding of the appropriate treatment plan.

Posted: 10/01/2021

Resources

Identifying Keratoconus Risk with Genetic Testing

View Resource

AvaGen™, The Genetic Eye Test in Modern Practice

View Resource

AvaGen Genetic Test Brochure for ECPs

View Resource

AvaGen Patient Brochure

View Resource

How CXL and Genetic Testing Fit Into the Keratoconus Game Plan

Listen to Episode

Genetic Testing Builds Confidence

Listen to Episode

Common Questions Patients Ask Genetic Counselors and How to Talk to Them About Testing

Listen to Episode

How are innovations in genetic testing affecting eyecare?

Listen to Episode

[Genetics and Eyecare Today] How Genetic Data Can Help Guide Decisions

Listen to Episode

[Genetics and Eyecare Today] The Role of Genetic Testing and Early Keratoconus Diagnosis

Listen to Episode

About Avellino

Avellino Lab USA, Inc. is a global leader in gene therapy and molecular diagnostics at the forefront of precision medicine for eye care and beyond. With a long-term mission to develop personalized approaches to improve health and disease management through genomics, the company is developing a transformative genetic diagnostics product pipeline, as well as gene therapeutics leveraging CRISPR gene editing, to better manage, and potentially cure, inherited diseases. Avellino is the first privately held, independent company to get an FDA Emergency Use Authorization (EUA).

Visit us online: avellino.com/en/ | avellino.com/en/products/avagen-test/